Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CIDEC pseudogene 2 (CIDECP2) is a genomic sequence highly homologous to the functional gene CIDEC (cell death-inducing DNA fragmentation factor-like effector C), but it is classified as a pseudogene and not believed to encode a functional protein. Pseudogenes like CIDECP2 have historically been considered genomic relics without function, though some pseudogenes may exert regulatory effects on gene expression of their parental genes. However, CIDECP2 specifically has no established biological function, disease association, or role as a therapeutic target. It is most relevant as a point of comparison in computational analyses involving pseudogene expression, where pseudogenes as a class may help stratify cancer subtypes or serve as non-coding RNA biomarkers.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CIDEC pseudogene 2 (CIDECP2).